XML 71 R54.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Investments in Non-Marketable Securities - Narrative (Details) - USD ($) $ in Thousands | 1 Months Ended | 3 Months Ended | 12 Months Ended |  |
--- | --- | --- | --- | --- | ---
Mar. 31, 2023 | Jul. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2024 | Sep. 30, 2024 | Dec. 31, 2023 | Sep. 30, 2023 | Sep. 30, 2022 | Dec. 31, 2024 | Dec. 31, 2023 | Dec. 31, 2022 | Nov. 30, 2023 | Mar. 31, 2022
Equity Securities without Readily Determinable Fair Value [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Investments in non-marketable securities |  |  |  |  |  |  |  |  | $ 0 | $ 1,191 | $ 5,300 |  |
Investment in non-marketable equity securities |  |  |  | $ 2,798 |  | $ 9,700 |  |  | 2,798 | 9,700 |  |  |
Revenues |  |  |  |  |  |  |  |  | 59,345 | 70,143 | 138,590 |  |
Impairment of investment in non-marketable securities |  |  |  |  |  |  |  |  | 6,902 | 12,215 | 0 |  |
Equity securities without readily determinable fair value, upward price adjustment, annual amount |  |  |  |  |  |  |  |  |  |  | 200 |  |
Equity securities without readily determinable fair value, upward (downward) price adjustment, annual amount |  |  |  |  |  |  |  |  | 0 | 0 |  |  |
Research and development revenue |  |  |  |  |  |  |  |  |  |  |  |  |
Equity Securities without Readily Determinable Fair Value [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Revenues |  |  |  |  |  |  |  |  | 22,559 | 27,237 | 21,914 |  |
seqWell | Research and development revenue |  |  |  |  |  |  |  |  |  |  |  |  |
Equity Securities without Readily Determinable Fair Value [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Revenues |  |  |  |  |  |  |  |  | $ 200 |  |  |  |
Common Stock | seqWell |  |  |  |  |  |  |  |  |  |  |  |  |
Equity Securities without Readily Determinable Fair Value [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Stock issued during period, shares, issued for services (in shares) |  |  |  |  |  |  |  |  | 205,279 |  |  |  |
seqWell |  |  |  |  |  |  |  |  |  |  |  |  |
Equity Securities without Readily Determinable Fair Value [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Equity securities without readily determinable fair value (in shares) |  |  |  |  |  |  |  |  |  |  |  |  | 1,000,000
Investment in non-marketable equity securities |  |  |  | 2,416 |  | 2,625 |  |  | $ 2,416 | 2,625 |  |  | $ 5,000
Impairment of investment in non-marketable securities |  |  |  | $ (2,800) |  |  | $ 3,000 |  | 200 |  |  |  |
Arzeda |  |  |  |  |  |  |  |  |  |  |  |  |
Equity Securities without Readily Determinable Fair Value [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Impairment of investment in non-marketable securities |  |  |  |  |  | $ 1,200 |  |  |  |  |  |  |
Related Party | Research and development revenue |  |  |  |  |  |  |  |  |  |  |  |  |
Equity Securities without Readily Determinable Fair Value [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Revenues |  |  |  |  |  |  |  |  | $ 0 | 0 | $ 1,245 |  |
MAI |  |  |  |  |  |  |  |  |  |  |  |  |
Equity Securities without Readily Determinable Fair Value [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Impairment of investment in non-marketable securities |  |  |  |  | $ (3,900) |  |  |  |  |  |  |  |
MAI |  |  |  |  |  |  |  |  |  |  |  |  |
Equity Securities without Readily Determinable Fair Value [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Impairment of investment in non-marketable securities |  |  |  |  |  |  |  |  |  | $ 8,000 |  |  |
Series B Preferred Stock | MAI | Related Party |  |  |  |  |  |  |  |  |  |  |  |  |
Equity Securities without Readily Determinable Fair Value [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Milestone payments received (in shares) |  | 1,587,049 | 1,587,049 |  |  |  |  | 1,587,049 |  |  |  |  |
Series B Preferred Stock | Arzeda |  |  |  |  |  |  |  |  |  |  |  |  |
Equity Securities without Readily Determinable Fair Value [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Equity securities without readily determinable fair value (in shares) |  |  |  |  |  |  |  |  |  |  |  | 207,070 |
Series B Preferred Stock | MAI |  |  |  |  |  |  |  |  |  |  |  |  |
Equity Securities without Readily Determinable Fair Value [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Investment owned, balance (in shares) | 985,545 |  |  |  |  |  |  |  |  |  |  |  |
Investments in non-marketable securities | $ 800 |  |  |  |  |  |  |  |  |  |  |  |
Common Stock | seqWell |  |  |  |  |  |  |  |  |  |  |  |  |
Equity Securities without Readily Determinable Fair Value [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Equity securities without readily determinable fair value (in shares) |  |  |  | 205,279 |  |  |  |  | 205,279 |  |  |  |
Common Stock | Arzeda |  |  |  |  |  |  |  |  |  |  |  |  |
Equity Securities without Readily Determinable Fair Value [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Convertible preferred stock, shares issued upon conversion (in shares) |  |  |  |  |  |  |  |  |  |  |  | 41,414 |
Series A and B Preferred Stock | MAI | Related Party |  |  |  |  |  |  |  |  |  |  |  |  |
Equity Securities without Readily Determinable Fair Value [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Noncash or part noncash acquisition, noncash financial or equity instrument consideration, shares issued (in shares) |  |  |  |  |  |  |  |  | 19,277,914 |  |  |  |
Series C-1 Preferred Stock | seqWell |  |  |  |  |  |  |  |  |  |  |  |  |
Equity Securities without Readily Determinable Fair Value [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Equity securities without readily determinable fair value (in shares) |  |  |  |  |  |  | 88,256 |  |  |  |  |  |
Common Stock Warrants | seqWell |  |  |  |  |  |  |  |  |  |  |  |  |
Equity Securities without Readily Determinable Fair Value [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Equity securities without readily determinable fair value (in shares) |  |  |  | 44,128 |  |  | 44,128 |  | 44,128 |  |  |  |
Investment in non-marketable equity securities |  |  |  |  |  |  | $ 400 |  |  |  |  |  |
Series C And C-1 Preferred Stock | seqWell |  |  |  |  |  |  |  |  |  |  |  |  |
Equity Securities without Readily Determinable Fair Value [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |
Equity securities without readily determinable fair value (in shares) |  |  |  | 1,088,256 |  |  |  |  | 1,088,256 |  |  |  |

X
- Definition Equity Securities Without Readily Determinable Fair Value, Realized Upward (Downward) Price Adjustment, Annual Amount + References No definition available. + Details
Name: | cdxs_EquitySecuritiesWithoutReadilyDeterminableFairValueRealizedUpwardDownwardPriceAdjustmentAnnualAmount
Namespace Prefix: | cdxs_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Equity Securities Without Readily Determinable Fair Value, Shares + References No definition available. + Details
Name: | cdxs_EquitySecuritiesWithoutReadilyDeterminableFairValueShares
Namespace Prefix: | cdxs_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Equity Securities Without Readily Determinable Fair Value, Shares, Milestone Payments Received + References No definition available. + Details
Name: | cdxs_EquitySecuritiesWithoutReadilyDeterminableFairValueSharesMilestonePaymentsReceived
Namespace Prefix: | cdxs_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of shares issued for each share of convertible preferred stock that is converted. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(27)) -SubTopic 10 -Topic 210 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-6 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 16 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-16 + Details
Name: | us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Amount of investment in equity security without readily determinable fair value. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 321 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479536/321-10-50-3 + Details
Name: | us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of impairment loss on investment in equity security without readily determinable fair value. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 321 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479536/321-10-50-3 + Details
Name: | us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 321 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479536/321-10-50-3 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 321 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479536/321-10-50-3 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 321 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479536/321-10-50-3 + Details
Name: | us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of gain from upward price adjustment on investment in equity security without readily determinable fair value. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 321 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479536/321-10-50-3 + Details
Name: | us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Number of shares of investment owned. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 55 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477439/946-210-55-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column B)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column B)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column B)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 + Details
Name: | us-gaap_InvestmentOwnedBalanceShares
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The number of shares issued as [noncash or part noncash] consideration for a business or asset acquired. Noncash is defined as transactions during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5 + Details
Name: | us-gaap_NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationSharesIssued1
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of cash outflow to acquire investments classified as other. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 230 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 13 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13 + Details
Name: | us-gaap_PaymentsToAcquireOtherInvestments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 41 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 270 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (ee) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 924 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 11.L) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 30 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 42 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 40 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4 + Details
Name: | us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders. + References No definition available. + Details
Name: | us-gaap_StockIssuedDuringPeriodSharesIssuedForServices
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | srt_ProductOrServiceAxis=cdxs_ResearchandDevelopmentRevenueMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=cdxs_SeqWellMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SecurityOwnedNotReadilyMarketableAxis=cdxs_SeqWellMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SecurityOwnedNotReadilyMarketableAxis=cdxs_ArzedaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_RelatedPartyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=cdxs_MolecularAssembliesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cdxs_MolecularAssembliesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=us-gaap_SeriesBPreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cdxs_ArzedaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=cdxs_SeriesAAndBPreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=cdxs_SeriesC1PreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=cdxs_CommonStockWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=cdxs_SeriesCAndC1PreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |